NIFTY MIDSML HLTH Index PE Ratio
NIFTY MIDSML HLTH Index PE Ratio. The NIFTY MIDSML HLTH P/E ratio is 56.85 on a market cap weighted basis, derived from the price-to-earnings data of 29 of 30 index constituents with valid EPS. Of these, 1 stocks trade at a low P/E ratio below 15, 3 at moderate valuations between 15 and 25, 12 at elevated earnings multiples between 25 and 50, and 13 at very high valuations above 50. Analyse NIFTY MIDSML HLTH constituent earnings to understand aggregate earnings trends across constituents. Use the NIFTY MIDSML HLTH PE ratio screener below to analyse the historical valuation trend, EPS distribution, and stock-level price-to-earnings data across all 30 constituents.
NIFTY MIDSML HLTH PE Ratio Distribution — Low, Moderate, High & Very High
1 low (<15), 3 moderate (15–25), 12 high (25–50), 13 very high (50+) among 30 NIFTY MIDSML HLTH stocks. Check NIFTY MIDSML HLTH index market cap trends to monitor the combined market capitalisation of all constituents.
NIFTY MIDSML HLTH PE Ratio Historical Trend — 6 Years
Market cap weighted P/E of NIFTY MIDSML HLTH over 6 years — 29 stocks with valid EPS, current P/E 56.85. For live index level, EPS data and the full index overview, see NIFTY MIDSML HLTH index composition.
NIFTY MIDSML HLTH Component Stocks — P/E Ratio & EPS
29 of 30 NIFTY MIDSML HLTH constituents with valid P/E — sorted by market cap weight.
| Company | Sector | Market Cap | EPS | PE Ratio |
|---|---|---|---|---|
|
LAURUSLABS
Laurus Labs
|
Healthcare | ₹1.1 Lakh Cr | ₹16.47 | 97.3 |
|
MANKIND
Mankind Pharma
|
Healthcare | ₹1.0 Lakh Cr | ₹46.35 | 49.5 |
|
AUROPHARMA
Aurobindo Pharma
|
Healthcare | ₹96.5K Cr | ₹60.34 | 26.0 |
|
LUPIN
Lupin
|
Healthcare | ₹92.0K Cr | ₹116.75 | 16.8 |
|
MAXHEALTH
Max Healthcare Institute
|
Healthcare … | ₹87.8K Cr | ₹14.83 | 61.2 |
|
GLENMARK
Glenmark Pharmaceuticals
|
Healthcare | ₹64.8K Cr | ₹48.26 | 36.7 |
|
ALKEM
Alkem Laboratories
|
Healthcare | ₹62.7K Cr | ₹192.51 | 28.1 |
|
BIOCON
Biocon
|
Healthcare | ₹60.3K Cr | ₹2.82 | 144.9 |
|
FORTIS
Fortis Healthcare
|
Healthcare … | ₹57.7K Cr | ₹13.80 | 55.4 |
|
ABBOTINDIA
Abbott
|
Healthcare | ₹55.5K Cr | ₹730.36 | 34.4 |
|
GLAND
Gland Pharma
|
Healthcare | ₹49.6K Cr | ₹62.35 | 42.6 |
|
IPCALAB
IPCA Laboratories
|
Healthcare | ₹49.3K Cr | ₹44.98 | 35.6 |
|
GLAXO
GlaxoSmithKline Pharmaceuticals
|
Healthcare | ₹44.6K Cr | ₹61.15 | 43.7 |
|
AJANTPHARM
Ajanta Pharma
|
Healthcare | ₹43.6K Cr | ₹84.53 | 39.4 |
|
ASTERDM
Aster DM Healthcare
|
Healthcare … | ₹42.1K Cr | ₹7.53 | 166.2 |
|
JBCHEPHARM
J B Chemicals and Pharmaceuticals
|
Healthcare | ₹40.2K Cr | ₹45.16 | 56.3 |
|
NH
Narayana Hrudayalaya
|
Healthcare … | ₹35.2K Cr | ₹39.67 | 43.1 |
|
MEDANTA
Global Health
|
Healthcare … | ₹35.0K Cr | ₹20.71 | 64.8 |
|
LALPATHLAB
Dr. Lal Path Labs
|
Healthcare … | ₹33.6K Cr | ₹30.24 | 60.5 |
|
KIMS
Krishna Institute of Medical Scien…
|
Healthcare … | ₹29.1K Cr | ₹6.03 | 151.6 |
|
NEULANDLAB
Neuland Laboratories
|
Healthcare | ₹27.6K Cr | ₹283.71 | 55.1 |
|
PPLPHARMA
Piramal Pharma
|
Healthcare | ₹26.7K Cr | - | N/A |
|
GRANULES
Granules
|
Healthcare | ₹20.3K Cr | ₹24.47 | 33.8 |
|
PFIZER
Pfizer
|
Healthcare | ₹17.7K Cr | ₹157.92 | 24.1 |
|
COHANCE
Cohance Lifesciences
|
Healthcare | ₹17.5K Cr | ₹4.69 | 292.0 |
|
POLYMED
Poly Medicure
|
Healthcare | ₹16.4K Cr | ₹31.79 | 53.1 |
|
APLLTD
Alembic Pharmaceuticals
|
Healthcare | ₹16.3K Cr | ₹34.33 | 23.2 |
|
NATCOPHARM
Natco Pharma
|
Healthcare | ₹16.1K Cr | ₹79.20 | 14.1 |
|
SYNGENE
Syngene International
|
Healthcare | ₹14.5K Cr | ₹7.87 | 65.4 |
|
RAINBOW
Rainbow Childrens Medicare
|
Healthcare … | ₹12.6K Cr | ₹27.41 | 44.4 |
Track NIFTY MIDSML HLTH PE Analysis in Your Trading Journal
Use this PE ratio analysis to evaluate index valuation and make informed trading decisions. Monitor how PE trends affect your position sizing and market timing strategies.
Add NIFTY MIDSML HLTH Trade to Journal